XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/11/30/amgen-v-hospira-summary-parties-responsive-jmol-briefs/20%Monthly2018-07-25 14:45
https://www.bigmoleculewatch.com/2017/11/29/updates-on-coherus-pegfilgrastim-and-other-biosimilar-efforts/20%Monthly2018-05-25 20:40
https://www.bigmoleculewatch.com/2017/11/28/biocon-ltd-launches-bevacizumab-biosimilar-india/20%Monthly2018-01-23 18:44
https://www.bigmoleculewatch.com/2017/11/27/supreme-court-considers-constitutionality-ipr-statute/20%Monthly2018-07-25 14:46
https://www.bigmoleculewatch.com/2017/11/27/bpcia-litigation-roundup-fall-2017/20%Monthly2018-06-04 14:56
https://www.bigmoleculewatch.com/2017/11/23/celltrion-seeks-interlocutory-appeal-of-standing-issue-in-janssen-v-celltrion/20%Monthly2018-05-25 20:35
https://www.bigmoleculewatch.com/2017/11/22/theradiag-partners-biogen-infliximab-monitoring-kits/20%Monthly2018-01-23 19:05
https://www.bigmoleculewatch.com/2017/11/21/article-regarding-citizen-petitions-goodwins-scott-lassman/20%Monthly2019-05-14 13:03
https://www.bigmoleculewatch.com/2017/11/21/amgen-files-reply-in-support-of-motion-to-transfer-bevacizumab-action-to-california/20%Monthly2018-01-23 19:07
https://www.bigmoleculewatch.com/2017/11/21/genentech-files-complaint-against-pfizer-regarding-herceptin/20%Monthly2018-01-23 19:09
https://www.bigmoleculewatch.com/2017/11/20/genentech-moves-dismiss-amgens-california-bevacizumab-dj-action/20%Monthly2018-01-23 19:13
https://www.bigmoleculewatch.com/2017/11/20/samsung-bioepis-receives-eu-marketing-authorization-trastuzumab-biosimilar/20%Monthly2018-01-23 19:15
https://www.bigmoleculewatch.com/2017/11/17/ipr-updates-2/20%Monthly2018-07-25 14:52
https://www.bigmoleculewatch.com/2017/11/15/sandoz-announces-new-data-for-its-adalimumab-and-rituximab-biosimilars/20%Monthly2018-01-31 20:49
https://www.bigmoleculewatch.com/2017/11/15/fda-announces-new-draft-rems-guidance/20%Monthly2018-07-25 14:53
https://www.bigmoleculewatch.com/2017/11/14/federal-circuit-provides-guidance-on-statements-in-patent-dance-letters-and-sunovion-in-amgen-v-apotex/20%Monthly2018-05-25 20:30
https://www.bigmoleculewatch.com/2017/11/13/boehringer-ingelheims-first-biosimilar-approved-europe/20%Monthly2018-01-31 20:44
https://www.bigmoleculewatch.com/2017/11/13/breaking-news-federal-circuit-affirms-district-court-amgen-v-apotex/20%Monthly2018-07-25 14:54
https://www.bigmoleculewatch.com/2017/11/10/biosimilars-update-amgen-allergan-pfenex-cinfa/20%Monthly2018-02-02 16:11
https://www.bigmoleculewatch.com/2017/11/10/janssen-voluntarily-dismisses-infliximab-patent-suit-against-samsung-bioepis/20%Monthly2018-07-25 14:55
https://www.bigmoleculewatch.com/2017/11/10/ptab-adopts-new-attorney-client-privilege-rule-pto-trial-proceedings-extending-protection-patent-agents-foreign-patent-practitioners/20%Monthly2018-01-31 20:36
https://www.bigmoleculewatch.com/2017/11/09/cms-announces-new-policy-biosimilars-payments-part-b/20%Monthly2017-11-09 20:54
https://www.bigmoleculewatch.com/2017/11/08/genentech-opposes-transfer-delaware-mvasi-bevacizumab-awwb-litigation-california/20%Monthly2018-07-25 14:56
https://www.bigmoleculewatch.com/2017/11/07/mylan-resubmits-ema-applications-trastuzumab-pegfilgrastim/20%Monthly2018-01-31 20:32
https://www.bigmoleculewatch.com/2017/11/06/new-data-supports-efficacy-safety-boehringer-ingelheims-cyltezo-humira-biosimilar/20%Monthly2018-01-31 20:29
https://www.bigmoleculewatch.com/2017/11/04/ptab-permits-amicus-briefing-in-connection-with-the-st-regis-mohawk-tribes-motions-to-terminate-iprs-based-on-tribal-sovereign-immunity/20%Monthly2018-01-31 20:27
https://www.bigmoleculewatch.com/2017/11/03/q3-earnings-calls/20%Monthly2018-01-31 20:25
https://www.bigmoleculewatch.com/2017/11/02/biosimilar-litigation-updates/20%Monthly2018-05-25 20:34
https://www.bigmoleculewatch.com/2017/11/02/momentas-orencia-abatacept-biosimilar-candidate-m834-not-meet-primary-endpoints-phase-study/20%Monthly2018-07-25 14:58
https://www.bigmoleculewatch.com/2017/11/01/fda-accepts-roches-sbla-avastin/20%Monthly2018-07-25 15:02